Citius Pharmaceuticals Statistics
Total Valuation
CTXR has a market cap or net worth of $14.82 million. The enterprise value is $11.04 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTXR has 27.45 million shares outstanding. The number of shares has increased by 138.25% in one year.
| Current Share Class | 27.45M |
| Shares Outstanding | 27.45M |
| Shares Change (YoY) | +138.25% |
| Shares Change (QoQ) | +4.10% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 3.47% |
| Float | 26.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.64 |
| Forward PS | 0.38 |
| PB Ratio | 0.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.58 |
| Quick Ratio | 0.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -123.03 |
Financial Efficiency
Return on equity (ROE) is -83.60% and return on invested capital (ROIC) is -52.22%.
| Return on Equity (ROE) | -83.60% |
| Return on Assets (ROA) | -27.63% |
| Return on Invested Capital (ROIC) | -52.22% |
| Return on Capital Employed (ROCE) | -72.42% |
| Weighted Average Cost of Capital (WACC) | 11.43% |
| Revenue Per Employee | $243,974 |
| Profits Per Employee | -$2.01M |
| Employee Count | 23 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.06 |
Taxes
In the past 12 months, CTXR has paid $561,510 in taxes.
| Income Tax | 561,510 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.00% in the last 52 weeks. The beta is 0.98, so CTXR's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -55.00% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 40.53 |
| Average Volume (20 Days) | 284,780 |
Short Selling Information
The latest short interest is 4.88 million, so 17.79% of the outstanding shares have been sold short.
| Short Interest | 4.88M |
| Short Previous Month | 4.95M |
| Short % of Shares Out | 17.79% |
| Short % of Float | 18.11% |
| Short Ratio (days to cover) | 8.11 |
Income Statement
In the last 12 months, CTXR had revenue of $5.61 million and -$46.20 million in losses. Loss per share was -$2.56.
| Revenue | 5.61M |
| Gross Profit | 4.49M |
| Operating Income | -56.15M |
| Pretax Income | -54.89M |
| Net Income | -46.20M |
| EBITDA | -53.85M |
| EBIT | -56.15M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $4.59 million in cash and $808,162 in debt, giving a net cash position of $3.78 million or $0.14 per share.
| Cash & Cash Equivalents | 4.59M |
| Total Debt | 808,162 |
| Net Cash | 3.78M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 69.08M |
| Book Value Per Share | 2.75 |
| Working Capital | -23.33M |
Full Balance SheetCash Flow
| Operating Cash Flow | -31.60M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.29M |
| Net Borrowing | n/a |
| Free Cash Flow | -31.60M |
| FCF Per Share | -$1.15 |
Full Cash Flow StatementMargins
| Gross Margin | 80.07% |
| Operating Margin | -1,000.56% |
| Pretax Margin | -978.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |